Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Neovascular age-related macular degeneration (nAMD) is a major cause of visual impairment and blindness. Anti-vascular endothelial growth factor (VEGF) agents, such as ranibizumab, bevacizumab, aflibercept, brolucizumab and faricimab have revolutionized the clinical management of nAMD. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Khachigian, Levon M., Liew, Gerald, Teo, Kelvin Y. C., Wong, Tien Y., Mitchell, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942398/
https://www.ncbi.nlm.nih.gov/pubmed/36810060
http://dx.doi.org/10.1186/s12967-023-03937-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942398/
https://www.ncbi.nlm.nih.gov/pubmed/36810060
http://dx.doi.org/10.1186/s12967-023-03937-7

Ejemplares similares